Efficacy of Brodalumab in Patients with Psoriasis and Risk Factors for Treatment Failure: A Review of Post Hoc Analyses.

Saved in:
Bibliographic Details
Title: Efficacy of Brodalumab in Patients with Psoriasis and Risk Factors for Treatment Failure: A Review of Post Hoc Analyses.
Authors: Lebwohl MG; Icahn School of Medicine at Mount Sinai, 5 East 98 Street, 5 Floor, New York, NY, 10029, USA. lebwohl@aol.com., Armstrong AW; University of California, Los Angeles, CA, USA., Alexis AF; Weill Cornell Graduate School of Medical Sciences, New York, NY, USA., Lain EL; Austin Institute for Clinical Research, Austin, TX, USA., Jacobson AA; Bausch Health Companies Inc, Bridgewater, NJ, USA.
Source: Dermatology and therapy [Dermatol Ther (Heidelb)] 2024 Oct; Vol. 14 (10), pp. 2709-2726. Date of Electronic Publication: 2024 Sep 12.
Publication Type: Journal Article; Review
Journal Info: Publisher: Springer Healthcare Communications Country of Publication: Switzerland NLM ID: 101590450 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2193-8210 (Print) NLM ISO Abbreviation: Dermatol Ther (Heidelb) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2193-8210
DOI:10.1007/s13555-024-01264-3